HMGB1 in health and disease

R Kang, R Chen, Q Zhang, W Hou, S Wu, L Cao… - Molecular aspects of …, 2014 - Elsevier
Complex genetic and physiological variations as well as environmental factors that drive
emergence of chromosomal instability, development of unscheduled cell death, skewed …

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing …

J Rodríguez-Carrio, A Burska, PG Conaghan… - RMD open, 2023 - rmdopen.bmj.com
Background Type I interferons (IFN-I) contribute to a broad range of rheumatic and
musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of …

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

A Burska, J Rodríguez-Carrio, R Biesen, WA Dik… - RMD open, 2023 - rmdopen.bmj.com
Objectives To systematically review the literature for assay methods that aim to evaluate type
I interferon (IFN-I) pathway activation and to harmonise-related terminology. Methods Three …

[HTML][HTML] Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry

S Rodriguez-Fernandez, I Pujol-Autonell… - Frontiers in …, 2018 - frontiersin.org
Type 1 diabetes (T1D) is a metabolic disease caused by the autoimmune destruction of
insulin-producing β-cells. With its incidence increasing worldwide, to find a safe approach to …

The many ways tissue phagocytes respond to dying cells

JM Blander - Immunological reviews, 2017 - Wiley Online Library
Apoptosis is an important component of normal tissue physiology, and the prompt removal of
apoptotic cells is equally essential to avoid the undesirable consequences of their …

[PDF][PDF] Dendritic cells as key players in systemic lupus erythematosus

C Kaewraemruaen, P Ritprajak… - Asian Pacific Journal of …, 2020 - apjai-journal.org
Abstract System lupus erythematosus (SLE) is a chronic autoimmune disorder affecting
multiple organs, and persistent disease activity is associated with increased morbidity and …

HMGB1 in systemic lupus erythematosus

T Liu, M Son, B Diamond - Frontiers in immunology, 2020 - frontiersin.org
The high-mobility group box 1 (HMGB1) has been shown to exert proinflammatory effects on
many cells of the innate immune system. Originally identified as a nuclear protein, HMGB1 …

Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease

Y Tanaka, M Kusuda, Y Yamaguchi - Modern Rheumatology, 2023 - academic.oup.com
Type I interferons (IFNs) have recently received a lot of attention with the elucidation of the
pathogenesis of systemic lupus erythematosus (SLE). Type I IFNs are associated with many …

Complement system and alarmin HMGB1 crosstalk: for better or worse

C Gaboriaud, M Lorvellec, V Rossi… - Frontiers in …, 2022 - frontiersin.org
Our immune system responds to infectious (PAMPs) and tissue damage (DAMPs) signals.
The complement system and alarmin High-Mobility Group Box 1 (HMGB1) are two powerful …

Beyond apoptosis in lupus

L Colonna, C Lood, KB Elkon - Current opinion in rheumatology, 2014 - journals.lww.com
Dysregulation of different forms of programmed cell death contributes to increased
exposure, availability, and immunogenic characteristics of intracellular self antigens, which …